voice search
Bimat Eye Drops - 0.03% W/v Bimatoprost Liquid | Reduces Elevated Intraocular Pressure, Designed For Ocular Hypertension And Open Angle Glaucoma Relief

Bimat Eye Drops - 0.03% W/v Bimatoprost Liquid | Reduces Elevated Intraocular Pressure, Designed For Ocular Hypertension And Open Angle Glaucoma Relief

Price Trend: 4.10-4.78 USD / Bottle

Get Latest Price

Minimum Order Quantity :

100 Bottle

Brand Name :

Bimat

In Stock

In Stock

Product Specifications

Drug TypeExternal Use Drugs
IngredientsBIMETAPROST ,03% W/V
Physical FormLiquid
FunctionOther
Recommended ForOCULAR HYPERTENSION,GLAUCOMA
DosageDrugs A to Z Bimatoprost Dosage Print Share Bimatoprost Ophthalmic Dosage Medically reviewed by Drugs.com. Last updated on Apr 27, 2020. Overview Side Effects Dosage Professional Interactions More Applies to the following strengths: 0.01%; 0.03%; 10 mcg Usual Adult Dose for: Intraocular Hypertension Glaucoma (Open Angle) Usual Pediatric Dose for: Intraocular Hypertension Glaucoma (Open Angle) Additional dosage information: Renal Dose Adjustments Liver Dose Adjustments Precautions Dialysis Other Comments Usual Adult Dose for Intraocular Hypertension One drop in the affected eye(s) once a day in the evening Comments: -If more than one topical ophthalmic drug is being used, the other drugs should be administered at least 5 minutes apart. -This drug should not be administered more than once a day as more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering. -Reduction of the intraocular pressure starts approximately 4 hours after first administration, with maximum effect reached within approximately 8 to 12 hours. Use: Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension
Dosage GuidelinesAS ABOVE
Quantity200 Unit
Storage InstructionsROOM TEMP. 10 -30 C
Payment TermsCash in Advance (CID)
Supply Ability1000 Per Day
Delivery Time2 Week
Sample PolicySample costs shipping and taxes has to be paid by the buyer
Packaging Details1 UNIT OF 3 ML
Main Export Market(s)Australia, South America, Western Europe, Middle East, Central America, Asia, North America, Africa
Main Domestic MarketWest India

Product Overview

Key Features

Bimat Eye Drop is a medicine used to reduce pressure in the eyes in adults with glaucoma and high pressure in the eye. If the pressure in your eye is too high it can damage your sight, potentially leading to blindness. It works by helping fluid flow from inside the eye into the blood.

Company Details

SHRESTHA GLOBAL PHARMA, Established in 2003 at Nagpur in Maharashtra, is a leading Exporter,Supplier,Trading Company of Common Medicines & Drugs in India. SHRESTHA GLOBAL PHARMA is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Bimat Drops, SHRESTHA GLOBAL PHARMA has made a reputed name for itself in the market with high-quality 1.5 gm Meropenem and Sulbactam For Injection, 13.9% w/w Eflornithine, 300 mg Cefdinir Capsules, etc.
Focusing on a customer-centric approach, SHRESTHA GLOBAL PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from SHRESTHA GLOBAL PHARMA at Trade India quality-assured products.

Business Type

Exporter, Supplier, Trading Company

Employee Count

10

Establishment

2003

Working Days

Monday To Sunday

GST NO

27ADJPR6506L1Z1

Payment Mode

Cash in Advance (CID)

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 27ADJPR6506L1Z1

3 RatingRating

Nagpur, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Proprietor

Mr Saroj Roy

Address

B No. 95, Aradhana Colony, Nara Road, Jaripatka, Nagpur, Maharashtra, 440014, India

bimat eye drops in Nagpur

Report incorrect details

Compare With Similar Products

Buyer Feedback

3

3

5

Price Or Price Range

4.10-4.78 USD ($) (Approx.)

72 INR (Approx.)

Minimum Order Quantity

100 Bottle/Bottles

100 Box/Boxes

100 Piece/Pieces

Drug Type

External Use Drugs

Other Types

Physical Form

Liquid

Liquid

Function

Other

Treat ENT Issues

Recommended For

OCULAR HYPERTENSION,GLAUCOMA

Adult and Children

Dosage

Drugs A to Z Bimatoprost Dosage Print Share Bimatoprost Ophthalmic Dosage Medically reviewed by Drugs.com. Last updated on Apr 27, 2020. Overview Side Effects Dosage Professional Interactions More Applies to the following strengths: 0.01%; 0.03%; 10 mcg Usual Adult Dose for: Intraocular Hypertension Glaucoma (Open Angle) Usual Pediatric Dose for: Intraocular Hypertension Glaucoma (Open Angle) Additional dosage information: Renal Dose Adjustments Liver Dose Adjustments Precautions Dialysis Other Comments Usual Adult Dose for Intraocular Hypertension One drop in the affected eye(s) once a day in the evening Comments: -If more than one topical ophthalmic drug is being used, the other drugs should be administered at least 5 minutes apart. -This drug should not be administered more than once a day as more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering. -Reduction of the intraocular pressure starts approximately 4 hours after first administration, with maximum effect reached within approximately 8 to 12 hours. Use: Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension

As prescribed by the physician

Dosage Guidelines

AS ABOVE

As prescribed by the physician

Storage Instructions

ROOM TEMP. 10 -30 C

Store at room temperature (10-30AdegC)

Payment Terms

Cash in Advance (CID)

Others, Cash in Advance (CID)

Supply Ability

1000 Per Day

1000 Per Week

200 Per Day

Delivery Time

2 Week

1 Week

7 Days

Sample Policy

Sample costs shipping and taxes has to be paid by the buyer

Free samples available with shipping and taxes paid by the buyer

Main Export Market(s)

Australia, South America, Western Europe, Middle East, Central America, Asia, North America, Africa

Australia, North America, Eastern Europe, Western Europe, Middle East, Central America, South America, Asia, Africa

Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa